Ishimaru, Sae
Shimoi, Tatsunori
Sunami, Kuniko
Nakajima, Miho
Ando, Yayoi
Okita, Natsuko
Nakamura, Kenichi
Shibata, Taro
Fujiwara, Yasuhiro
Yamamoto, Noboru http://orcid.org/0000-0002-0787-2851
Funding for this research was provided by:
Japan Agency for Medical Research and Development (20ck0106622h0001)
Ministry of Health, Labour and Welfare (19EA1008)
Article History
Received: 17 June 2023
Accepted: 8 November 2023
First Online: 19 December 2023
Declarations
:
: The study drugs were provided by Novartis Pharma K.K., CHUGAI PHARMACEUTICAL Co., Ltd., ONO PHARMACEUTICAL Co., Ltd., Pfizer Japan Inc., Otsuka Pharmaceutical Co., Ltd., and Eli Lilly and Company. ONO PHARMACEUTICAL Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. provided financial support for drug delivery. All other authors declare no potential conflicts of interest.